Product Information
LIDOCAINE-HC 3-2.5% GEL KIT is a generic product labeled by Seton Pharmaceuticals, priced at $99.5503 per EA under NDC 13925016420. Its NADAC has been published 185 times since Dec 18, 2013.
Strength
25; 30 mg/g; mg/g
Manufacturer
Seton PharmaceuticalsNDC
13925016420
Classification
Generic
Dosage Form
GEL
Route
RECTAL
Effective Date
4/23/2025
Active Ingredients
HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
6/17/2011
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE-HC 3-2.5% GEL KIT has been published 185 times since Dec 18, 2013, and over the history we have for it it has declined 61.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $99.5503 per EA |
|---|---|
| All-time high | $255.2740 (Feb 12, 2014) |
| All-time low | $99.5503 (Apr 23, 2025) |
| Median price | $209.1700 |
| Average price | $198.7095 |
| Largest weekly change | -40.7% (Apr 17, 2024) |
| Weeks tracked | 185 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-58.6%
5Y
-58.6%
All
-61.0%
Last surveyed Apr 23, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lidocaine Hydrochloride and Hydrocortisone Acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Seton Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride and Hydrocortisone Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE-HC 3-2.5% GEL KIT?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE-HC 3-2.5% GEL KIT, manufactured by Seton Pharmaceuticals, is $99.5503 per EA (NDC 13925016420), effective Apr 23, 2025.
How has the price of LIDOCAINE-HC 3-2.5% GEL KIT changed over time?
Over the history we have for it, the NADAC for LIDOCAINE-HC 3-2.5% GEL KIT has declined 61.0%. It has been tracked across 185 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for LIDOCAINE-HC 3-2.5% GEL KIT?
Since Dec 18, 2013, the NADAC for LIDOCAINE-HC 3-2.5% GEL KIT has ranged from a low of $99.5503 (Apr 23, 2025) to a high of $255.2740 (Feb 12, 2014), with a median of $209.1700 per EA.
Are there cheaper alternatives to LIDOCAINE-HC 3-2.5% GEL KIT?
No other NADAC-published product currently shares the active ingredient and strength of LIDOCAINE-HC 3-2.5% GEL KIT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LIDOCAINE-HC 3-2.5% GEL KIT?
LIDOCAINE-HC 3-2.5% GEL KIT (NDC 13925016420) is labeled by Seton Pharmaceuticals, and CMS classifies it as a generic product.